Document Detail


Pentoxifylline down-regulates adhesion molecule expression and inflammatory cytokine production in cultured peripheral blood mononuclear cells from patients with HTLV-I-associated myelopathy.
MedLine Citation:
PMID:  9058776     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
To clarify if pentoxifylline (PTX) may have therapeutic potential for human T-cell lymphotropic virus type I (HTLV-I)-associated myelopathy (HAM), we investigated the in vitro effect of PTX on spontaneous proliferation of peripheral blood lymphocytes (SPP), as well as on the expression of adhesion molecules, such as lymphocyte function antigen-1 (LFA-1) and very late activation antigen-4 (VLA-4), and the production of inflammatory cytokines, such as tumor necrosis factor-alpha (TNF-alpha), interferon-gamma (IFN-gamma) and granulocyte-monocyte colony stimulating factor (GM-CSF), in cultured PBMC from 10 HAM patients, compared with control subjects. SPP in HAM patients was significantly suppressed in a dose-dependent manner with PTX. Using flow cytometry, PTX was found to down-regulate the expression of LFA-1 and VLA-4 on CD4+ and CD8+ T cells in HAM patients as well as control subjects. However, the fall in the expression of LFA-1 and VLA-4 on CD4+ T cell population in HAM patients was higher than that of control subjects. PTX caused a significant suppression of spontaneous production of TNF-alpha by cultured PBMC of HAM patients. It also caused a small but significant suppression GM-CSF and IFN-gamma production. Collectively, our results suggest that PTX might be therapeutically effective at critical points in the immunopathogenesis of HAM.
Authors:
A Tsujino; T Nakamura; Y Nishiura; S Shirabe; T Furuya; H Goto; A Kawakami; K Eguchi; S Nagataki
Related Documents :
9844926 - Gm-csf receptor targeted treatment of primary aml in scid mice using diphtheria toxin f...
22022446 - Age-related impairment of ultrasonic vocalization in tau.p301l mice: possible implicati...
12718936 - Induction of cd69 activation molecule on human neutrophils by gm-csf, ifn-gamma, and if...
1697806 - Survival enhancement and hemopoietic regeneration following radiation exposure: therape...
23159286 - Comparative study between the effect of methotrexate and valproic acid on solid ehrlich...
22739506 - P-glycoprotein is a major determinant of norbuprenorphine brain exposure and antinocice...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Journal of neuroimmunology     Volume:  73     ISSN:  0165-5728     ISO Abbreviation:  J. Neuroimmunol.     Publication Date:  1997 Mar 
Date Detail:
Created Date:  1997-04-08     Completed Date:  1997-04-08     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  8109498     Medline TA:  J Neuroimmunol     Country:  NETHERLANDS    
Other Details:
Languages:  eng     Pagination:  191-6     Citation Subset:  IM; X    
Affiliation:
First Department of Internal Medicine, Nagasaki University School of Medicine, Sakamoto, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Antigens, CD4 / analysis
Antigens, CD8 / analysis
Cell Adhesion Molecules / biosynthesis*
Cell Division / drug effects
Cells, Cultured
Cytokines / antagonists & inhibitors
Female
Humans
Male
Middle Aged
Monocytes / immunology,  metabolism*,  pathology
Paraparesis, Tropical Spastic / blood,  metabolism*,  pathology
Pentoxifylline / pharmacology*
Phosphodiesterase Inhibitors / pharmacology*
Reference Values
Chemical
Reg. No./Substance:
0/Antigens, CD4; 0/Antigens, CD8; 0/Cell Adhesion Molecules; 0/Cytokines; 0/Phosphodiesterase Inhibitors; 6493-05-6/Pentoxifylline

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Modulation of behavioral and neurochemical measures of forebrain dopamine function in mice by specie...
Next Document:  Competitive PCR quantification of pro- and anti-inflammatory cytokine mRNA in the central nervous sy...